Vol.

No.

February 23, 2024Feb 23, 2024

DOWNLOAD THE PDF

An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief” How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs

Cover Story

Free

An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”

How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs

By Alexandria Carolan

A cruel reminder crept in alongside the joy that overcame Shauna Erickson-Abou Zahr and Abdallah Abou Zahr at the birth of their daughter, Nadia Carmel, on Jan. 11.

Clinical

First-ever commercial TIL therapy: How NCI, Iovance, and Moffitt achieved FDA approval

By Matthew Bin Han Ong

Conversation with The Cancer Letter

Steven Rosenberg, Friedrich Graf Finckenstein: FDA recognition of TIL therapy is the result of 40 years of research

By Matthew Bin Han Ong

Black History Month Free In the Archives

Roderic Pettigrew, founding director of NIBIB, reflects on a career as a “physicianeer”— merging medicine with engineering

By Robert A. Winn and Alexandria Carolan

In Brief

Chi Van Dang to receive 2024 AACR-Margaret Foti Award

Seanne Falconer named administrative director at Tulane Cancer Center

Kay Macleod named associate director for basic sciences at UChicago

UChicago Medicine opens Center to Eliminate Cancer Inequity

Damian Green named chief of Division of Transplantation & Cellular Therapy at Sylvester

Caroline Germa named CMO at Ikena Oncology

CPRIT approves nearly $99M in grants

UPMC Hillman Cancer Center at UPMC Horizon starts cancer care expansion

Tampa General Hospital Cancer Institute earns National Pancreas Foundation designation

OU Health Stephenson Cancer Center earns Center of Excellence for Rectal Cancer accreditation

Regeneron Science Talent Search showcases exceptional young leaders with innovative ideas in STEM

House Energy and Commerce Committee Democratic leaders urge FDA to advance clinical trial diversity efforts

Jill DeSimone joins Swim Across America’s board of directors

Clinical Roundup

NCI launches research network to evaluate emerging cancer screening technologies

Hopkins study: Immune cell receptor provides promising immunotherapy target

Study at Mt. Sinai reveals insights into immune system’s role in lung cancer risk

UCLA study: Promising target for CAR T-cell therapy leads to potent antitumor responses against cutaneous and rare melanomas

Wistar scientists discover link between leaky gut and accelerated biological aging

AI-aided colonoscopy improves ADR

Drugs & Targets

FDA approves Tagrisso + chemo for EGFR-mutated NSCLC

Linvoseltamab BLA accepted for Priority Review for R/R multiple myeloma

FDA OCE annual report lists 83 cancer therapeutic approvals in 2023

Mainz Biomed and Praxisdienst form distribution partnership for ColoAlert

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 52 | Issue 05 - February 06, 2026